Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA
Date
2016-09
Journal Title
Journal ISSN
Volume Title
Publisher
Impact Journals
Abstract
ENGLISH ABSTRACT: Activated B-cells increase T-cell behaviour during autoimmune disease and other infections by means of cytokine production and antigen-presentation. Functional studies in experimental autoimmune encephalomyelitis (EAE) indicate that B-cell deficiencies, and a lack of IL10 and IL35 leads to a poor prognosis. We hypothesised that B-cells play a role during tuberculosis. We evaluated B-cell mRNA expression using real-time PCR from healthy community controls, individuals with other lung diseases and newly diagnosed untreated pulmonary TB patients at three different time points (diagnosis, month 2 and 6 of treatment).
We show that FASLG, IL5RA, CD38 and IL4 expression was lower in B-cells from TB cases compared to healthy controls. The changes in expression levels of CD38 may be due to a reduced activation of B-cells from TB cases at diagnosis. By month 2 of treatment, there was a significant increase in the expression of APRIL and IL5RA in TB cases. Furthermore, after 6 months of treatment, APRIL, FASLG, IL5RA and CD19 were upregulated in B-cells from TB cases. The increase in the expression of APRIL and CD19 suggests that there may be restored activation of B-cells following anti-TB treatment. The upregulation of FASLG and IL5RA indicates that B-cells expressing regulatory genes may play an important role in the protective immunity against M.tb infection. Our results show that increased activation of B-cells is present following successful TB treatment, and that the expression of FASLG and IL5RA could potentially be utilised as a signature to monitor treatment response.
Description
CITATION: Van Rensburg, I. C., et al. 2016. Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA. Oncotarget, doi:10.18632/oncotarget.12184
The original publication is available at http://www.impactjournals.com/oncotarget
Publication of this article was funded by the Stellenbosch University Open Access Fund.
The original publication is available at http://www.impactjournals.com/oncotarget
Publication of this article was funded by the Stellenbosch University Open Access Fund.
Keywords
Lungs -- Tuberculosis -- Treatment, Messenger RNA, Autoimmune diseases, B cells
Citation
Van Rensburg, I. C., et al. 2016. Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA. Oncotarget, doi:10.18632/oncotarget.12184